Campaigner delighted at £160m boost to cancer drug fund

Clive Stone with David Cameron in 2010

Clive Stone with David Cameron in 2010

First published in News

Cancer campaigner Clive Stone has welcomed news of a £160m boost to a drug fund set up following his fight for drug treatment.

The Government announced last week that £80m would be added to the annual £200m Cancer Drugs Fund for each of the next two years.

The fund was set up in 2011 to give patients access to cancer drugs not routinely available on the NHS.

It was announced by Prime Minister and Witney MP David Cameron in 2010 after Mr Stone, 66, lobbied him following his successful fight to be treated with kidney cancer drug Sunitinib in 2007.

Mr Stone, from Eynsham, who has had 34 brain tumours removed, has written to Mr Cameron to praise the move.

He said: “I’m over the moon. It’s incredible.

“We know that at least for the next two years we will get cancer drugs — especially for people with rarer cancers.

“It won’t necessarily save lives but it will extend lives. Some people may be saved, because, if they get the drug at the right time, they could be cured.”

He said: “This is very good for the drug side of things but I hope we can complete it and I will keep pushing to make sure we get all the radiotherapy we need.”

Health Secretary Jeremy Hunt said: “It’s vitally important that as many people as possible have access to these pioneering, life-enhancing drugs.”

  • Do you want alerts delivered straight to your phone via our WhatsApp service? Text NEWS or SPORT or NEWS AND SPORT, depending on which services you want, and your full name to 07767 417704. Save our number into your phone's contacts as Oxford Mail WhatsApp and ensure you have WhatsApp installed.


Our top stories

 

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree